Literature DB >> 29157599

Skin lesions of Birt-Hogg-Dubé syndrome: Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts.

Chikako Iwabuchi1, Hiroki Ebana2, Akira Ishiko3, Azusa Negishi4, Teruaki Mizobuchi5, Toshio Kumasaka6, Masatoshi Kurihara5, Kuniaki Seyama7.   

Abstract

BACKGROUND: Birt-Hogg-Dubé syndrome (BHDS) (OMIM #135150) is an autosomal dominant disease, characterized by fibrofolliculomas (FFs) of the skin, pulmonary cysts with/without pneumothorax, and renal tumors. The prevalence of skin manifestations reported for Japanese BHDS patients is lower (<30%) compared with that of Western countries (75∼90%), which appear to be underestimated.
OBJECTIVE: To precisely examine the prevalence of skin lesions with dermoscopy and histopathology with reference to genetic analyses.
METHODS: We studied 31 patients (47.0±13.2years old, range 15-71) consisting of 26 unrelated families consecutively from May 2013 to June 2015 specifically for skin-colored papules on their faces and cervicothoracic regions. Patients initially suspected of BHDS from multiple pulmonary cysts that resulted in pneumothorax (30/31; 96.8%) received dermoscopic examinations and skin biopsies if applicable. The diagnosis of BHDS was established by folliculin (FLCN) genetic testing, and the results were compared to the histopathological findings of FFs or trichodiscomas (TDs).
RESULTS: FLCN germline mutation was demonstrated in 25/26 (96.2%) unrelated families tested and 28/29 patients (96.6%) tested. Skin lesions were recognized in 26/31 patients (83.9%); skin biopsies were performed in 23 patients of whom FFs and/or TDs were histologically demonstrated in 17 (73.9%). Although our study population included patients whose skin manifestations were evaluated prior to or after FLCN genetic testing, skin lesions were clearly prevalent and recognizable irrespective of whether genetic testing was or wasn't done. When examined with dermoscopy, distinct FFs appeared as well-demarcated areas of pallor with central follicular openings in 13 of 15 FF-bearing patients (86.7%); however, those manifestations were not recognized for TD.
CONCLUSIONS: Skin lesions appear to be more prevalent than previously reported (<30% vs.73.9%) in Japanese BHDS patients. Dermoscopy is a useful diagnostic aid for finding FFs.
Copyright © 2017 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Birt-Hogg-Dubé syndrome; Dermoscopy; FLCN gene; Fibrofolliculoma; Trichodiscoma

Mesh:

Substances:

Year:  2017        PMID: 29157599     DOI: 10.1016/j.jdermsci.2017.10.014

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  11 in total

Review 1.  Birt-Hogg-Dubé syndrome in Chinese patients: a literature review of 120 families.

Authors:  Xiaowen Hu; Guofeng Zhang; Xianmeng Chen; Kai-Feng Xu
Journal:  Orphanet J Rare Dis       Date:  2021-05-17       Impact factor: 4.303

2.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

3.  Kidney cancer characteristics and genotype-phenotype-correlations in Birt-Hogg-Dubé syndrome.

Authors:  Elke C Sattler; Marlene Reithmair; Ortrud K Steinlein
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

4.  Cystic lung disease in Birt-Hogg-Dubé syndrome. A case series.

Authors:  Vasilios Tzilas; Dimitrios Sgouros; Zannis Almpanis; Demosthenes Bouros; Argyrios Tzouvelekis
Journal:  Respir Med Case Rep       Date:  2020-05-06

5.  The clinical characteristics of East Asian patients with Birt-Hogg-Dubé syndrome.

Authors:  Ting Guo; Qinxue Shen; Ruoyun Ouyang; Min Song; Dandan Zong; Zhihui Shi; Yingjiao Long; Ping Chen; Hong Peng
Journal:  Ann Transl Med       Date:  2020-11

6.  A retrospective two centre study of Birt-Hogg-Dubé syndrome reveals a pathogenic founder mutation in FLCN in the Swedish population.

Authors:  Kristina Lagerstedt-Robinson; Izabella Baranowska Körberg; Stefanos Tsiaprazis; Erik Björck; Emma Tham; Anna Poluha; Maritta Hellström Pigg; Ylva Paulsson-Karlsson; Magnus Nordenskjöld; Maria Johansson-Soller; Christos Aravidis
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

7.  Novel folliculin gene mutations in Polish patients with Birt-Hogg-Dubé syndrome.

Authors:  Elżbieta Radzikowska; Urszula Lechowicz; Jolanta Winek; Lucyna Opoka
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

Review 8.  The Skin in Cowden Syndrome.

Authors:  Agnes Lim; Joanne Ngeow
Journal:  Front Med (Lausanne)       Date:  2021-06-10

9.  FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome.

Authors:  Haiyan Min; Dehua Ma; Wei Zou; Yongzheng Wu; Yibing Ding; Chengchu Zhu; Anqi Lin; Shiyu Song; Qiao Liang; Baofu Chen; Bin Zhang; Yueming Wan; Minhua Ye; Yanqing Pan; Yanting Wen; Long Yi; Qian Gao
Journal:  Thorax       Date:  2020-03-17       Impact factor: 9.139

10.  A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours.

Authors:  Kenki Matsumoto; Derek Lim; Paul D Pharoah; Eamonn R Maher; Stefan J Marciniak
Journal:  Eur J Hum Genet       Date:  2021-07-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.